For a patient with a history of lymphedema and breast cancer treated with chemotherapy one year ago and radiation a few months ago, who presents with left lower‑extremity swelling and a Doppler showing left femoral and distal deep venous thrombosis, pending a computed tomography angiography (CTA) of the chest, no personal or family history of thrombosis, no pain or paresthesia, intact pedal pulses, and recent left‑arm lymphedema, how should I write the vascular surgery consult note?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Vascular Surgery Consult Note Structure for Cancer-Associated DVT

For this patient with breast cancer-associated femoral DVT, your vascular surgery consult should focus on ruling out acute limb-threatening complications, determining candidacy for catheter-directed therapy, and establishing the anticoagulation plan—not on surgical intervention, as this patient has no indication for vascular surgery based on current evidence.

Critical Assessment Points to Document

Immediate Vascular Status

Document the following specific findings that indicate this is not an acute limb-threatening emergency:

  • Pedal pulses present bilaterally (confirms adequate arterial perfusion)
  • No pain or paresthesias (rules out phlegmasia cerulea dolens)
  • Ambulatory status preserved (patient can walk)
  • No signs of venous gangrene or limb compromise

Note: The Doppler showed DVT in the femoral vein (not artery as stated—this is critical to clarify in your note). 1

Cancer-Specific Thrombosis Context

Your note must include:

  • Breast cancer status: Completed chemotherapy 1 year ago, radiation completed months ago (currently in surveillance phase)
  • Active cancer treatment: None currently
  • Bilateral lymphedema: Pre-existing lymphedema history, new left arm lymphedema 2 weeks ago
  • Thrombosis risk factors: Recent radiation (within months), history of chemotherapy, lymphedema suggesting lymphatic dysfunction 1

DVT Characterization

Document precisely:

  • Location: Left femoral vein extending distally (proximal lower extremity DVT)
  • Extent: Specify exact veins involved from ultrasound report
  • Symptomatology: Unilateral leg swelling without pain (atypical presentation—80% of cancer-associated DVT presents with edema, 75% with pain per MASTER registry) 1
  • Pending studies: CTA chest to evaluate for PE

Vascular Surgery Consultation Question

The primary question for vascular surgery is whether this patient is a candidate for catheter-directed therapy (pharmacomechanical thrombolysis or mechanical thrombectomy). 1

Candidacy Criteria to Address

According to NCCN guidelines, appropriate candidates for catheter-directed therapy include: 1

  • Patients at risk of limb loss (e.g., phlegmasia cerulea dolens) — NOT present in this case
  • Patients with central thrombus propagation despite anticoagulation — NOT applicable (not yet anticoagulated)
  • Patients with moderate to severely symptomatic proximal DVT — Questionable; patient is asymptomatic regarding pain

This patient does NOT meet clear criteria for catheter-directed intervention given:

  • No limb-threatening features
  • Minimal symptoms (no pain, ambulatory)
  • Intact perfusion

IVC Filter Consideration

Document that IVC filter is NOT indicated because: 1

  • No contraindication to anticoagulation exists
  • Patient has normal platelet count (implied by ability to anticoagulate)
  • No active bleeding
  • IVC filters are only for patients with contraindications to anticoagulation

Recommended Management Plan

Anticoagulation (Primary Treatment)

Initiate therapeutic anticoagulation immediately while awaiting CTA results if high clinical suspicion exists. 1

For cancer-associated VTE, first-line options include: 1

  • LMWH: Enoxaparin 1 mg/kg SC every 12 hours OR Dalteparin 200 units/kg SC daily
  • Direct oral anticoagulants (DOACs): Apixaban, rivaroxaban, or edoxaban (apixaban may be safer for GI lesions)

Duration: Minimum 3-6 months, potentially indefinite given cancer history 2

Graduated Compression Stockings

Consider graduated compression stockings (GCS) only if patient tolerates therapeutic anticoagulation, though note that GCS did not reduce post-thrombotic syndrome incidence in randomized trials. 1

Serial Monitoring

Document plan for:

  • Clinical monitoring during anticoagulation
  • Follow-up imaging only if symptoms progress (not routine) 1
  • Evaluation of CTA chest results for PE

Key Differential Consideration

The bilateral lymphedema pattern (pre-existing + new left arm involvement) raises concern for:

  • Lymphatic dysfunction contributing to venous stasis 3
  • Possible central venous obstruction (SVC syndrome)—CTA will evaluate this
  • Radiation-induced vascular/lymphatic damage 4

Document that the new left arm lymphedema 2 weeks ago may represent progression of lymphatic dysfunction rather than isolated DVT phenomenon, though DVT can occur in cancer patients with lymphedema. 3

Conclusion for Vascular Surgery

Your consult note should conclude that this patient requires medical anticoagulation management rather than surgical/interventional vascular procedures. The vascular surgery team should document:

  • No indication for catheter-directed therapy (not limb-threatening, minimally symptomatic)
  • No indication for IVC filter (no contraindication to anticoagulation)
  • Recommend medical management with therapeutic anticoagulation
  • Recommend follow-up only if symptoms worsen or anticoagulation fails

If vascular surgery declines the consult or recommends medical management, this is appropriate and expected based on current guidelines. 1

References

1
Guideline

cancer-associated venous thromboembolic disease, version 2.2024, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2024

Related Questions

How does lymphedema develop?
How should lymphoedema resulting from axillary lymph‑node clearance for breast carcinoma be managed?
What imaging should be obtained to evaluate unilateral arm swelling in a cancer patient after a negative Doppler ultrasound?
Is exposure to cold environments advisable for a patient with hand lymphedema four years after a radical mastectomy?
For a generally healthy premenopausal woman with depression and no contraindications (no history of breast cancer, venous thromboembolism, active liver disease, and smoking ≤15 cigarettes per day), is an estrogen transdermal patch appropriate as primary treatment for depression?
Why should a Foley catheter be left in place for 3–7 days when a micro‑perforation is suspected after repeat transurethral resection of bladder tumor (TURBT)?
What are the causes of adhesive capsulitis (frozen shoulder)?
What is the appropriate management for a 2-year-old child with influenza A?
What are the most common posterior‑fossa brain tumors in children?
Should a child older than two years be treated with oseltamivir?
When are corticosteroids indicated in leptospirosis, and what is the recommended dosing regimen for severe cases such as massive pulmonary hemorrhage or fulminant meningitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.